Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT00259805
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of chronic focal encephalitis
* IgG \& IgM levels within normal limits
* Adequate renal function
* Stable anticonvulsant drug regimen
Exclusion Criteria:
* Evidence of significant ongoing medical condition or progressive neurologic condition (other than CFE)
* Previous treatment with rituximab
* History of significant recurrent infections, or ongoing active infection
* Receipt of a live vaccine within 4 weeks prior to treatment
* History of severe allergic reactions to humanized or murine monoclonal antibodies
* History of drug, alcohol or chemical abuse within 6 months
* Concomitant malignancies or previous malignancy
* Use of steroids or immunoglobulins during the 4 weeks prior to treatment
* Hemoglobin \<8.5 gm/dL, Platelets \< 100,00/mm, AST or ALT \>2.5 ULN
* Positive Hepatitis B or C serology
* History of positive HIV
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
25 Years
Study:
NCT00259805
Study Brief:
Protocol Section:
NCT00259805